Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Pediatric Hematology and Oncology|January 26, 2019
High-dose chemotherapy and autologous hematopoietic stem-cell rescue for treatment of relapsed and refractory Wilms tumor: Re-evaluating outcomesJenna Rossoff, William T Tse, Reggie E Duerst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology GroupJennifer Schneiderman, Wendy B London, Garrett M Brodeur, et al.
Hematology/Oncology and Stem Cell Therapy|February 5, 2018
Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host diseaseLarisa Broglie, Alfred Rademaker, John Galvin, et al.
Pediatric Blood & Cancer|March 8, 2017
Early mixed T-cell chimerism is predictive of pediatric AML or MDS relapse after hematopoietic stem cell transplantLarisa Broglie, Irene Helenowski, Lawrence J Jennings, et al.
Journal of Pediatric Hematology/Oncology|November 8, 2016
The Impact of High-resolution HLA-A, HLA-B, HLA-C, and HLA-DRB1 on Transplant-related Outcomes in Single-unit Umbilical Cord Blood Transplantation in Pediatric PatientsAmy E Armstrong, Eileen Smyth, Irene B Helenowski, et al.
Transplantation and Cellular Therapy|May 8, 2026
Excellent long-term survival and immune recovery with reduced-intensity conditioning HCT in inborn errors of immunityHannah Lust, Olatundun Williams, Jennifer Schneiderman, et al.
Journal of Clinical Apheresis|October 10, 2013
An international survey of pediatric apheresis practiceMeghan Delaney, Kelley E Capocelli, Anne F Eder, et al.
Pediatric Transplantation|April 16, 2011
Allogeneic hematopoetic stem cell transplantation in pediatric myelodysplastic syndromes: improved outcomes for de novo diseaseJeffrey R Andolina, Morris Kletzel, William T Tse, et al.
Pageof 4